Tyra Biosciences (TYRA) Interest Expenses (2020 - 2023)

Tyra Biosciences (TYRA) has 7 years of Interest Expenses data on file, last reported at $324.4 million in Q1 2026.

• Quarterly Interest Expenses rose 2309.45% year-over-year to $324.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $324.4 million (up 2309.45% YoY) and the FY2025 annual result came in at $186.7 million, up 452.31% from the prior year.
• Interest Expenses improved to $324.4 million in Q1 2026, from $200000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $324.4 million in Q1 2026 to a low of -$150000.0 in Q4 2022.
• A 5-year average of $53.9 million and a median of $40.0 million in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses jumped 19838.0% — and 2025, when it tumbled 76.31%.
• Tracing TYRA's Interest Expenses over 5 years: stood at -$150000.0 in 2022, then jumped by 26752.0% to $40.0 million in 2023, then slumped by 99.25% to $300000.0 in 2024, then plunged by 33.33% to $200000.0 in 2025, then surged by 162116.5% to $324.4 million in 2026.
• The last three Interest Expenses figures came in at $324.4 million (Q1 2026), $200000.0 (Q4 2025), and $46.0 million (Q3 2025), per Business Quant data.